Portola Pharma Posts Loss - Quick Facts

(RTTNews) - Portola Pharmaceuticals Inc. (PTLA) Thursday reported second-quarter net loss to common stock of $21.6 million or $1.47 per share, compared with net profit of $3.3 million or $1.67 per share last year.

Loss-per-share results for the quarter reflected a higher share count.

Collaboration and license revenues for the quarter were $2.6 million, compared with $67 million in the prior year.

Analysts polled by Thomson Reuters estimated a loss of $0.71 per share on revenues of $3.11 million for the quarter. Analysts' estimates typically exclude special items.